The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 9, 2009, Pages 1179-1183

  Ørn, Stein ^a,b   Breland, Unni M ^c   Mollnes, Tom Eirik ^c   Manhenke, Cord ^a   Dickstein, Kenneth ^a,b   Aukrust, Pål ^c   Ueland, Thor ^c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE; CLOPIDOGREL; CXCL16 CHEMOKINE; CXCL7 CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEUROHORMONE; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; FEMALE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE INJURY; HEART SCINTISCANNING; HEART VENTRICLE REMODELING; HUMAN; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT DURATION;

ANGIOPLASTY, BALLOON, CORONARY; CARDIAC OUTPUT; CHEMOKINES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TROPONIN T; VENTRICULAR REMODELING;

EID: 71749088822     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.028     Document Type: Article

References (27)

1. Kervinen H., Manttari M., Kaartinen M., Makynen H., Palosuo T., Pulkki K., and Kovanen P.T. Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes. Am J Cardiol 94 (2004) 993-996
2. de Jager S.C., Kraaijeveld A.O., Grauss R.W., de Jager W., Liem S.S., van der Hoeven B.L., Prakken B.J., Putter H., van Berkel T.J., Atsma D.E., Schalij M.J., Jukema J.W., and Biessen E.A. CCL3 (MIP-1alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. J Mol Cell Cardiol 45 (2008) 446-452
3. Judd R.M., Lugo-Olivieri C.H., Arai M., Kondo T., Croisille P., Lima J.A., Mohan V., Becker L.C., and Zerhouni E.A. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92 (1995) 1902-1910
4. Ørn S., Manhenke C., Ueland T., Damas J.K., Mollnes T.E., Edvardsen T., Aukrust P., and Dickstein K. C-reactive protein, infarct size, microvascular obstruction and left ventricular remodeling following acute myocardial infarction. Eur Heart J 10 (2009) 1180-1186
5. Aukrust P., Halvorsen B., Yndestad A., Ueland T., Oie E., Otterdal K., Gullestad L., and Damas J.K. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 28 (2008) 1909-1919
6. Zernecke A., Shagdarsuren E., and Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 28 (2008) 1897-1908
7. Kanda T., Hirao Y., Oshima S., Yuasa K., Taniguchi K., Nagai R., and Kobayashi I. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 77 (1996) 304-307
8. Pannitteri G., Marino B., Campa P.P., Martucci R., Testa U., and Peschle C. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol 80 (1997) 622-625
9. Akasaka Y., Morimoto N., Ishikawa Y., Fujita K., Ito K., Kimura-Matsumoto M., Ishiguro S., Morita H., Kobayashi Y., and Ishii T. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol 19 (2006) 588-598
10. Kukielka G.L., Smith C.W., LaRosa G.J., Manning A.M., Mendoza L.H., Daly T.J., Hughes B.J., Youker K.A., Hawkins H.K., and Michael L.H. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95 (1995) 89-103
11. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., and Luster A.D. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104 (1999) 1041-1050
12. van Wanrooij E.J., de Jager S.C., van Es T., de Vos P., Birch H.L., Owen D.A., Watson R.J., Biessen E.A., Chapman G.A., van Berkel T.J., and Kuiper J. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28 (2008) 251-257
13. Koten K., Hirohata S., Miyoshi T., Ogawa H., Usui S., Shinohata R., Iwamoto M., Kitawaki T., Kusachi S., Sakaguchi K., and Ohe T. Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size. Clin Biochem 41 (2008) 30-37
14. Aslanian A.M., and Charo I.F. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114 (2006) 583-590
15. Sheikine Y., and Sirsjo A. CXCL16/SR-PSOX-a friend or a foe in atherosclerosis?. Atherosclerosis 197 (2008) 487-495
16. Smith C., Halvorsen B., Otterdal K., Waehre T., Yndestad A., Fevang B., Sandberg W.J., Breland U.M., Froland S.S., Oie E., Gullestad L., Damas J.K., and Aukrust P. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovasc Res 79 (2008) 195-203
17. Gislason G.H., Jacobsen S., Rasmussen J.N., Rasmussen S., Buch P., Friberg J., Schramm T.K., Abildstrom S.Z., Kober L., Madsen M., and Torp-Pedersen C. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 113 (2006) 2906-2913
18. Aukrust P., Yndestad A., Waehre T., Gullestad L., Halvorsen B., and Damas J.K. Inflammation in coronary artery disease: potential role for immunomodulatory therapy. Expert Rev Cardiovasc Ther 3 (2005) 1111-1124
19. Arslan F., de Kleijn D.P., Timmers L., Doevendans P.A., and Pasterkamp G. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. Curr Pharm Des 14 (2008) 1205-1216
20. Frangogiannis N.G. The immune system and cardiac repair. Pharmacol Rev 58 (2008) 88-111
21. Franke A., Lante W., Fackeldey V., Becker H.P., Kurig E., Zoller L.G., Weinhold C., and Markewitz A. Pro-inflammatory cytokines after different kinds of cardiothoracic surgical procedures: is what we see what we know?. Eur J Cardiothoracic Surg 28 (2005) 569-575
22. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860-878
23. Kraaijeveld A.O., de Jager S.C., de Jager W.J., Prakken B.J., McColl S.R., Haspels I., Putter H., van Berkel T.J., Nagelkerken L., Jukema J.W., and Biessen E.A. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation 116 (2007) 1931-1941
24. Damas J.K., Smith C., Oie E., Fevang B., Halvorsen B., Waehre T., Boullier A., Breland U., Yndestad A., Ovchinnikova O., Robertson A.K., Sandberg W.J., Kjekshus J., Tasken K., Froland S.S., Gullestad L., Hansson G.K., Quehenberger O., and Aukrust P. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 27 (2007) 614-620
25. Parish C.R. The role of heparan sulphate in inflammation. Nat Rev Immunol 6 (2006) 633-643
26. Tziakas D.N., Chalikias G.K., Tentes I.K., Stakos D., Chatzikyriakou S.V., Mitrousi K., Kortsaris A.X., Kaski J.C., and Boudoulas H. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. Eur Heart J 29 (2008) 2713-2722
27. Vandervelde S., van Luyn M.J., Rozenbaum M.H., Petersen A.H., Tio R.A., and Harmsen M.C. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res 73 (2007) 783-793